<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210404050830N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-11-12</date_registration>
      <primary_sponsor>Karaj University of Medical Sciences</primary_sponsor>
      <public_title>effect of maouthwash contains punica granatum extract on periodontitis</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation the effect of mouth wash contains punica granatum extract in comparison with chlorhexidine mouth wash on improvement of periodontal index in chronic mild to moderate periodontitis</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-04-09</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/55324</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Triple blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: In this study, we will use the block randomization method. This method is usually used to balance the number of samples assigned to each of the study groups. The size of all blocks is equal and in this two-group experiment, we will have 4 blocks of 8 (including 4 people participating in the intervention group and 4 people participating in the control group), Due to the possibility of people not attending the follow-up sessions, 2 people are considered more than the sample size. The site https://www.sealedenvelope.com/simple has been used for random assignment of individuals to groups.
In this method we use sealed envelopes with a random sequence. Each of the random sequences created is recorded on a card and the cards are placed inside the envelopes in order. In order to maintain a random sequence, the envelopes are numbered in the same way on the outer surface. Finally, the lids of the envelopes are glued and placed inside a box, respectively. At the beginning of the registration of participants, according to the order of entry of eligible participants into the study, one of the envelopes open in order and the assigned group of the participant is revealed, Blinding description: The codes for each group will be kept in a closed envelope. After the person is eligible to enter the study, based on the obtained sequence, one of the two interventions will be performed for him. The solutions are in the same jars and are similar in color and size, and no one untill the end of the study, when the research report is being prepared, neither the researcher, nor the assistant, nor the participant has any knowledge that labels A or B belong to the intervention or control group.</study_design>
      <phase>3</phase>
      <hc_freetext>Chronic mild to moderate periodontitis..</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: Before any intervention,The patient will be taught how to brush and floss properly and how to use mouthwash properly for 15 minutes.Then all the variables, including the depth of the periodontal pocket and gingival index and clinical attachment loss and bleeding during probing(by WHO periodontal probe) and bacterial culture are recorded in the patient's file at the first meeting before any intervention. Then scaling is done by ultrasonic scaler for the patient. up to two weeks after scaling the patient uses mouthwash containing 2 percent  punica granatum extract that produced by Pharmacy Faculty of Alborz University of Medical Sciencestwice a day. 1 month later and 3 months after scaling, the patient is called to re-examine the gingival markers. Then the results are compared with the results of control group. Intervention 2: control group: Before any intervention,The patient will be taught how to brush and floss properly and how to use mouthwash properly for 15 minutes.Then all the variables, including the depth of the periodontal pocket and gingival index and the amount ofclinical attachment loss and bleeding during probing(by WHO periodontal probe) and bacterial culture are recorded in the patient's file at the first meeting before any intervention. Then scaling is done by ultrasonic scaler for the patient. up to two weeks after scaling the patient uses mouthwash containing 0.2  percent chlorhexidine(NAJO)  twice a day. 1 month later and 3 months after scaling, the patient is called to re-examine the gingival markers.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is right now I didnt make decision to publish or not.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Ali Bayat</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Number20, West 5th, Tohid ave,Tehranpars, Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1653636411</zip>
        <telephone>+98 21 4465 4507</telephone>
        <email>alibt77@gmail.com</email>
        <affiliation>Karaj University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Ali Bayat</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Number 20, west 5th, street Tohid ave., Tehranpars, Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1653636411</zip>
        <telephone>+98 21 4465 4507</telephone>
        <email>alibt77@gmail.com</email>
        <affiliation>Karaj University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>not alcohol consumer
non smoker
not pregnant
no antibiotic usage
no allergic reaction
not breastfeeding
no  systematic disease
mild to moderate chronic periodontitis</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>K05.3</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Chronic periodontitis</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: Before any intervention,The patient will be taught how to brush and floss properly and how to use mouthwash properly for 15 minutes.Then all the variables, including the depth of the periodontal pocket and gingival index and clinical attachment loss and bleeding during probing(by WHO periodontal probe) and bacterial culture are recorded in the patient's file at the first meeting before any intervention. Then scaling is done by ultrasonic scaler for the patient. up to two weeks after scaling the patient uses mouthwash containing 2 percent  punica granatum extract that produced by Pharmacy Faculty of Alborz University of Medical Sciencestwice a day. 1 month later and 3 months after scaling, the patient is called to re-examine the gingival markers. Then the results are compared with the results of control group.</i_keyword>
      <i_keyword>control group: Before any intervention,The patient will be taught how to brush and floss properly and how to use mouthwash properly for 15 minutes.Then all the variables, including the depth of the periodontal pocket and gingival index and the amount ofclinical attachment loss and bleeding during probing(by WHO periodontal probe) and bacterial culture are recorded in the patient's file at the first meeting before any intervention. Then scaling is done by ultrasonic scaler for the patient. up to two weeks after scaling the patient uses mouthwash containing 0.2  percent chlorhexidine(NAJO)  twice a day. 1 month later and 3 months after scaling, the patient is called to re-examine the gingival markers.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Periodontal pocket depth. Timepoint: before intervention, after 1 month, after 3 month. Method of measurement: with WHO periodontal probe.</prim_outcome>
      <prim_outcome>Clinical attachement loss. Timepoint: before intervention, after 1 month, after 3 month. Method of measurement: with WHO periodontal probe.</prim_outcome>
      <prim_outcome>Gingival index. Timepoint: before intervention, after 1 month, after 3 month. Method of measurement: with WHO periodontal probe.</prim_outcome>
      <prim_outcome>Bleeding on probing. Timepoint: before intervention, after 1 month, after 3 month. Method of measurement: with WHO periodontal probe.</prim_outcome>
      <prim_outcome>Bacterial culture. Timepoint: before intervention, after 1 month, after 3 month. Method of measurement: pharmacoupe culture.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Karaj University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-01-19</approval_date>
        <contact_name>Ethics committee of Alborz University of Medical Sciences</contact_name>
        <contact_address>Katooei st, Golshahr, Karaj Karaj Alborz Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
